GRAIL Inc

Research GRAIL Inc (GRAL) on Bullrun: market cap USD 2.94B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGRAL
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Market capUSD 2.94B
• Financial periodFY2025
• RevenueUSD 147.17M
• Revenue growth17.2%
• Net income-USD 408.35M
• Free cash flow-USD 299.92M

Valuation Snapshot

latest market cap is USD 2.94B.

About GRAIL Inc

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development.

Frequently asked questions

What is GRAIL Inc's market cap?

GRAIL Inc's market capitalization is USD 2.94B.

What does GRAIL Inc do?

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age;